I Gilron… - Regional Anesthesia and Pain Medicine, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > Current ... Cited by 2 - Related articles - All 3 versions
H Bonnefoi, A Potti, M Delorenzi, L Mauriac… - The lancet …, 2011 - ncbi.nlm.nih.gov Retraction-validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial. ... Bonnefoi H, Potti A, Delorenzi M, Mauriac L, Campone M, Tubiana-Hulin M, Petit T, Rouanet P, Jassem J, ... Cited by 4 - Related articles - All 4 versions
PD Miller, RB Wagman, M Peacock… - Journal of Clinical …, 2011 - Endocrine Soc Address all correspondence and requests for reprints to: Paul D. Miller, MD, Medical Director, Colorado Center for Bone Research, 3190 South Wadsworth Boulevard, Ste 250, Lakewood, Colorado 80227. E-mail: millerccbr{at}aol.com. ... Context:This is a study ... Cited by 12 - Related articles - All 4 versions
D Preiss, N Sattar… - American Heart Journal, 2011 - Elsevier Food and Drug Administration guidance now proposes that cardiovascular safety of new diabetes medicines be demonstrated. Consequently, trials should include a sufficient number of individuals with diabetes who are at high cardiovascular risk. We aimed to examine the impact of the ... Cited by 1 - Related articles - All 10 versions
EJA Morris, C Jordan, JD Thomas… - British Journal of …, 2011 - Wiley Online Library Survival and treatment data for those in the CLASICC trial were available in the NCDR for 98·9 and 95·8 per cent of patients respectively. There was agreement in operation type for 86·1 per cent of patients but surgical approach coding was poor, with only 58·4 per cent of ... Cited by 3 - Related articles - All 5 versions